4880.T
Price:
$395
Market Cap:
$7.83B
CellSource Co., Ltd. engages in the regenerative medicine-related and consumer businesses. It also offers Signalift, an anti-aging product. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.
Industry
Biotechnology
IPO Date
2019-10-29
Stock Exchange
JPX
Ticker
4880.T
According to CellSource Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 0.18%. This represents a change of 354.91% compared to the average of 0.04% of the last 4 quarters.
The mean historical ROE of CellSource Co., Ltd. over the last ten years is 21.94%. The current 0.18% ROE has changed -99.19% with respect to the historical average. Over the past ten years (40 quarters), 4880.T's ROE was at its highest in in the October 2022 quarter at 11.33%. The ROE was at its lowest in in the October 2024 quarter at -2.26%.
Average
21.94%
Median
14.88%
Minimum
0.18%
Maximum
53.60%
Discovering the peaks and valleys of CellSource Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 78.44%
Maximum Annual ROE = 53.60%
Minimum Annual Increase = -95.51%
Minimum Annual ROE = 0.18%
| Year | ROE | Change |
|---|---|---|
| 2025 | 0.18% | -95.51% |
| 2024 | 3.94% | -73.52% |
| 2023 | 14.88% | -44.64% |
| 2022 | 26.89% | 12.29% |
| 2021 | 23.95% | 78.44% |
| 2020 | 13.42% | 8.08% |
| 2019 | 12.42% | -74.24% |
| 2018 | 48.20% | -10.07% |
The current ROE of CellSource Co., Ltd. (4880.T) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
6.33%
5-year avg
13.97%
10-year avg
21.94%
CellSource Co., Ltd.’s ROE is greater than Stella Pharma Corporation (-5.94%), greater than MEDINET Co., Ltd. (-31.95%), greater than MediciNova, Inc. (-23.12%), greater than Chiome Bioscience Inc. (-56.15%), greater than NANO MRNA Co.,Ltd. (-27.51%), less than StemCell Institute Inc. (7.52%), less than GENOVA, Inc. (8.63%), less than Kohjin Bio Co., Ltd. (12.63%), greater than Linical Co., Ltd. (-17.16%), less than Kidswell Bio Corporation (16.80%),
| Company | ROE | Market cap |
|---|---|---|
| -5.94% | $7.59B | |
| -31.95% | $7.41B | |
| -23.12% | $11.18B | |
| -56.15% | $7.28B | |
| -27.51% | $9.91B | |
| 7.52% | $7.79B | |
| 8.63% | $9.86B | |
| 12.63% | $7.72B | |
| -17.16% | $6.64B | |
| 16.80% | $10.02B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CellSource Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CellSource Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is CellSource Co., Ltd.'s ROE?
How is the ROE calculated for CellSource Co., Ltd. (4880.T)?
What is the highest ROE for CellSource Co., Ltd. (4880.T)?
What is the 3-year average ROE for CellSource Co., Ltd. (4880.T)?
What is the 5-year average ROE for CellSource Co., Ltd. (4880.T)?
How does the current ROE for CellSource Co., Ltd. (4880.T) compare to its historical average?